In summary, our data suggest that FEN1 may promote cell cycle transition from G2 to M phase by modulating Cdc25C, CDK1 and Cyclin B1 expressions, thus promoting the proliferation of HCC cells. The gene discussed is CDK1; the disease is hepatocellular carcinoma.